Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Trial compares 1% Terbinafine vs 1% Clotrimazole C...
A randomized controlled trial showed that for Tinea pedis (athletic foot) management, 1 week Terbinafine twice a day is as effective as 4 weeks C...
3 min
Study reveals the effect of Isotretinoin on menstr...
Novel findings from a recent prospective observational study shed light on the impact of oral intake of Isotretinoin on menstrual cycles among ac...
1 min
Paracetamol vs Ibuprofen. Which is better for trea...
In a systematic review and meta-analysis, both Paracetamol and Ibuprofen demonstrated superior effectiveness compared to a placebo in addressing...
3 min
Study assesses efficacy of ketorolac for treatment...
In people presenting with migraine headache, ketorolac might have similar effectiveness when compared to phenothiazines and metoclopramide for mi...
3 min
Tirzepatide injection gets FDA approval for chroni...
According to the notification published on 8 Nov 2023, the United States Food and Drug Administration (US-FDA) has authorized Tirzepatide injecti...
4 min
Is alcohol safe for rheumatoid arthritis patients...
Rheumatoid Arthritis (RA) patients taking Methotrexate (MTX) are often advised to decrease their alcohol intake due to the increased risk of hepa...
2 min
Does exercise induce GERD or relieve acid reflux?...
Different factors are accountable for the impact of exercise or physical activity on the onset of gastroesophageal reflux disease (GERD), a sessi...
3 min
GERD Symptoms: Could Intermittent Fasting Help?
A study published in the "Journal of Clinical Gastroenterology" showed symptomatic relief in gastroesophageal reflux disease (GERD) sym...
2 min
Microneedling + minoxidil boosts hair regrowth in...
In a systematic review and meta-analysis, combining microneedling with minoxidil offered markedly better outcomes for individuals with androgenet...
1 min
Understanding bleeding patterns associated with ea...
A recent study published in the Maternal-Fetal Medicine Journal found that terminated bleeding after 2 weeks is a predictive indicator for effe...
2 min
Acute phase responses with IV bisphosphonates for osteoporosis: W...
Clinicians report varied approaches to managing IV bisphosphonate-associated acute phase responses in osteoporosis, with corticosteroids showing...
Which H. pylori treatment works best? Meta-analysis reveals effic...
Ten-day and PCAB-based regimens achieve relatively higher H. pylori eradication rates, whereas sequential and multi-antibiotic regimens are assoc...
Specialized care improves surgical outcomes for umbilical hernia...
Symptomatic umbilical hernia repair is feasible in selected patients with advanced chronic liver disease following meticulous preoperative optimi...
Extremely preterm birth linked to cognitive challenges at school...
Children born before 27 weeks show persistent cognitive vulnerability at 8 years, particularly those born at 22–23 weeks.
Vonoprazan vs. PPIs: Which acid blocker comes out ahead?
Vonoprazan emerges as a superior therapeutic alternative to traditional proton pump inhibitors for both Helicobacter pylori eradication and the m...
Second Asian consensus on functional dyspepsia: What’s new in dia...
Updated 2025 consensus guidance refines functional dyspepsia management with new mechanistic insights and personalized care recommendations.
FDA clears first oral PCSK9 inhibitor for management of high chol...
FDA approves enlicitide as the first oral PCSK9 inhibitor, delivering a groundbreaking once-daily pill option to slash "bad" cholestero...
Tapinarof 1% cream gains strong guideline support for children wi...
The 2026 AAD guidelines strongly recommend tapinarof 1% cream for children aged ≥2 years with atopic dermatitis. It is the only steroid-free t...
Etripamil nasal spray receives FDA approval for rapid relief of P...
FDA has approved intranasal etripamil for paroxysmal supraventricular tachycardia, delivering fast, on-demand restoration of normal heart rhythm....
FDA clears new oral therapy rilzabrutinib for treatment-resistant...
FDA approves rilzabrutinib tablets as a new oral treatment option for adults with persistent or chronic ITP who show insufficient response to sta...
FDA expands access to omalizumab therapy with first interchangeab...
The FDA has authorized omalizumab-igec as the first interchangeable biosimilar to omalizumab for treating asthma, urticaria, chronic rhinosinusit...
FDA introduces front-of-package nutrition labels to tackle chroni...
The FDA has proposed requisition of front-of-package nutrition labels on most packaged foods to clearly display levels of saturated fat, sodium,...
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.